Bevacizumab-Induced Hypertension

Authors:

Abstract
Bevacizumab, a recombinant humanized monoclonal antibody targeting the vascular endothelial growth factor (VEGF), has been approved in the US as first- and second-line treatment of colorectal cancer...

This publication has 56 references indexed in Scilit: